Automating Jardiance Prior Authorization for Efficiency

Navigating the complexities of Jardiance prior authorization can be a significant drain on revenue cycle operations. Klivira automates this critical process, integrating directly with your EMR and payer portals to streamline submissions and accelerate approvals.

For revenue cycle directors and prior authorization coordinators, managing the increasing volume of prior authorization requests for high-value medications like Jardiance (empagliflozin) presents persistent challenges. From intricate payer-specific criteria to the manual burden of documentation, delays directly impact patient care and your organization's financial health. Klivira offers a robust solution designed to mitigate these operational bottlenecks.

The Challenge of Jardiance Prior Authorization

Jardiance, an SGLT2 inhibitor prescribed for type 2 diabetes, heart failure, and chronic kidney disease, often requires prior authorization due to its cost and specific clinical guidelines. Payer policies frequently mandate step therapy, typically starting with metformin, and require detailed clinical documentation to justify its use. This necessitates meticulous adherence to dynamic criteria, leading to high administrative overhead and potential delays.

Common Hurdles in Jardiance PA Submissions

  • Keeping pace with evolving payer-specific criteria for empagliflozin.
  • Manual data entry and documentation collation from disparate EMR sources.
  • Frequent denials due to incomplete information or non-adherence to step therapy protocols.
  • Time-consuming follow-ups with payers via phone, fax, or portal.
  • Lack of real-time visibility into PA status across the entire workflow.

Klivira's Intelligent Automation for Jardiance PA

Klivira leverages advanced AI and machine learning to automate the entire Jardiance prior authorization workflow. Our platform ingests payer rules, extracts relevant clinical data from your EMR, and intelligently populates X12 278 transactions or payer-specific ePA forms. This reduces manual effort, minimizes errors, and ensures submissions align with current payer requirements, including step therapy validation.

Seamless EMR Integration and Payer Connectivity

Our platform integrates directly with leading EMR systems via SMART on FHIR, ensuring secure and efficient exchange of PHI. For Jardiance, this means clinical notes, lab results, and medication histories are automatically pulled to support the PA request. Klivira maintains real-time connections with payer portals and supports standard ePA protocols like X12 278 and NCPDP SCRIPT, facilitating rapid submission and status updates.

Tangible Benefits for Your Revenue Cycle

By automating Jardiance prior authorization, Klivira helps your organization achieve significant operational improvements. Expect reduced administrative burden on PA coordinators, faster turnaround times for approvals, and a lower denial rate for empagliflozin. This translates to improved patient access to critical therapies and a healthier revenue cycle.

Frequently asked questions

How does Klivira handle specific payer requirements for Jardiance?

Klivira maintains an up-to-date database of payer-specific clinical criteria for medications like Jardiance. Our AI engine cross-references this with patient data from your EMR to ensure all necessary documentation and clinical justifications, including step therapy compliance, are included in the submission, minimizing the risk of denial.

Can Klivira integrate with our EMR to pull patient data for Jardiance PAs?

Yes, Klivira is designed for seamless integration with major EMR systems using industry standards like SMART on FHIR. This allows our platform to securely access and extract relevant patient demographic, clinical, and medication history data, automatically populating Jardiance prior authorization forms without manual intervention.

What if a Jardiance PA requires an appeal? Does Klivira support that?

Klivira streamlines the appeal process by centralizing denial reasons and facilitating the submission of additional documentation. While the clinical rationale for an appeal remains your team's responsibility, our platform helps organize and expedite the administrative steps involved in re-submitting an appeal for Jardiance.

How does Klivira ensure compliance with HIPAA and PHI for Jardiance PA data?

Klivira operates with robust security protocols and strict adherence to HIPAA guidelines for handling PHI. All data transmissions are encrypted, access is role-based, and our platform is designed to maintain the confidentiality, integrity, and availability of patient information throughout the Jardiance prior authorization process. We recommend discussing specific compliance considerations with your internal compliance team.

Does Klivira support Da Vinci PAS for Jardiance prior authorizations?

Klivira is actively engaged with industry standards and supports the adoption of Da Vinci PAS (Prior Authorization Support) for real-time electronic prior authorization. This allows for more immediate determinations for medications like Jardiance, where supported by payers, further accelerating the approval process.

Related coverage

Automating prior authorization by payer

Automating prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo